BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24417780)

  • 1. Safety and success of the human papillomavirus vaccine: time for a robust vaccination program in the United States and worldwide.
    Duska LR
    Clin Ther; 2014 Jan; 36(1):4-7. PubMed ID: 24417780
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.
    Khan K; Curtis CR; Ekwueme DU; Stokley S; Walker C; Roland K; Benard V; Saraiya M
    Cancer; 2008 Nov; 113(10 Suppl):3004-12. PubMed ID: 18980296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV vaccine: implications for nurses and patients.
    Schmidt JV
    Nurs Womens Health; 2007 Feb; 11(1):83-7. PubMed ID: 17883822
    [No Abstract]   [Full Text] [Related]  

  • 4. HPV: a danger at any age.
    Avitzur O
    Consum Rep; 2012 Feb; 77(2):12. PubMed ID: 22368798
    [No Abstract]   [Full Text] [Related]  

  • 5. Human papillomavirus vaccination: expected impacts and unresolved issues.
    Dempsey AF; Freed GL
    J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
    [No Abstract]   [Full Text] [Related]  

  • 6. The Australian experience with the human papillomavirus vaccine.
    Garland SM
    Clin Ther; 2014 Jan; 36(1):17-23. PubMed ID: 24417782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HPV vaccine controversy.
    Intlekofer KA; Cunningham MJ; Caplan AL
    Virtual Mentor; 2012 Jan; 14(1):39-49. PubMed ID: 23116916
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
    Dillner J; Andrae B; Westermark B
    Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
    [No Abstract]   [Full Text] [Related]  

  • 10. Questions remain about the human papillomavirus vaccine.
    Printz C
    Cancer; 2009 Feb; 115(4):699-701. PubMed ID: 19189370
    [No Abstract]   [Full Text] [Related]  

  • 11. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus, vaccines and women's health: questions and cautions.
    Lippman A; Melnychuk R; Shimmin C; Boscoe M
    CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
    [No Abstract]   [Full Text] [Related]  

  • 13. Race, ethnicity, and income factors impacting human papillomavirus vaccination rates.
    Jeudin P; Liveright E; Del Carmen MG; Perkins RB
    Clin Ther; 2014 Jan; 36(1):24-37. PubMed ID: 24417783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One in four California adolescent girls have had human papillomavirus vaccination.
    Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
    Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
    [No Abstract]   [Full Text] [Related]  

  • 15. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
    Saslow D; Wheeler CM
    Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who should get the HPV vaccine?
    Pichichero ME
    J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic human papillomavirus vaccination: a breakthrough in primary cervical cancer prevention.
    Garcia FA; Saslow D
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):761-81, ix. PubMed ID: 18061868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for HPV immunization.
    Campos-Outcalt D
    J Fam Pract; 2009 Dec; 58(12):660-4. PubMed ID: 19961821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating human papillomavirus vaccination programs.
    Donovan B; Guy RJ
    Sex Transm Dis; 2013 Apr; 40(4):290-1. PubMed ID: 23481536
    [No Abstract]   [Full Text] [Related]  

  • 20. Playing games with girls' health: why it is too soon to mandate the HPV vaccine for pre-teen girls as a prerequisite to school entry.
    Gendel JE
    Seton Hall Law Rev; 2009; 39(1):265-90. PubMed ID: 19288617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.